{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T18:29:30Z","timestamp":1776450570995,"version":"3.51.2"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T00:00:00Z","timestamp":1687132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005876","name":"Biotieteiden ja Ymp\u00e4rist\u00f6n Tutkimuksen Toimikunta","doi-asserted-by":"publisher","award":["333010"],"award-info":[{"award-number":["333010"]}],"id":[{"id":"10.13039\/501100005876","id-type":"DOI","asserted-by":"publisher"}]},{"name":"State Research Funding of South-Western Finland"},{"DOI":"10.13039\/501100008087","name":"Suomen Anestesiologiyhdistys","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Aneurysmal subarachnoid hemorrhage (aSAH) is a neurological emergency, affecting a younger population than individuals experiencing an ischemic stroke; aSAH is associated with a high risk of mortality and permanent disability. The noble gas xenon has been shown to possess neuroprotective properties as demonstrated in numerous preclinical animal studies. In addition, a recent study demonstrated that xenon could attenuate a white matter injury after out-of-hospital cardiac arrest.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The study is a prospective, multicenter phase II clinical drug trial. The study design is a single-blind, prospective superiority randomized two-armed parallel follow-up study. The primary objective of the study is to explore the potential neuroprotective effects of inhaled xenon, when administered within 6 h after the onset of symptoms of aSAH. The primary endpoint is the extent of the global white matter injury assessed with magnetic resonance diffusion tensor imaging of the brain.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Discussion<\/jats:title>\n                <jats:p>Despite improvements in medical technology and advancements in medical science, aSAH mortality and disability rates have remained nearly unchanged for the past 10 years. Therefore, new neuroprotective strategies to attenuate the early and delayed brain injuries after aSAH are needed to reduce morbidity and mortality.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>ClinicalTrials.gov NCT04696523. Registered on 6 January 2021.<\/jats:p>\n                <jats:p>EudraCT, EudraCT Number: 2019-001542-17. Registered on 8 July 2020.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13063-023-07432-8","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T17:01:33Z","timestamp":1687194093000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effect of xenon on brain injury, neurological outcome, and survival in patients after aneurysmal subarachnoid hemorrhage\u2014study protocol for a randomized clinical trial"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-1879-0418","authenticated-orcid":false,"given":"Mikael","family":"Laaksonen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Rahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jussi P.","family":"Posti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruut","family":"Laitio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juri","family":"Kivelev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka","family":"Saarenp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Laukka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juhana","family":"Fr\u00f6sen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Ronkainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stepani","family":"Bendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"L\u00e5ngsj\u00f6","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marika","family":"Ala-Peijari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jani","family":"Saunavaara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riitta","family":"Parkkola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikko","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilkka K.","family":"Martikainen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex M.","family":"Dickens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Rinne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mika","family":"Valtonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teijo I.","family":"Saari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Koivisto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Bendel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Roine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antti","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tero","family":"Vahlberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juha","family":"Tanttari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Laitio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,6,19]]},"reference":[{"issue":"3","key":"7432_CR1","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1056\/NEJMcp1605827","volume":"377","author":"MT Lawton","year":"2017","unstructured":"Lawton MT, Vates GE. Subarachnoid hemorrhage. N Engl J Med. 2017;377(3):257\u201366.","journal-title":"N Engl J Med."},{"issue":"9558","key":"7432_CR2","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","volume":"369","author":"J van Gijn","year":"2007","unstructured":"van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid haemorrhage. Lancet. 2007;369(9558):306\u201318.","journal-title":"Lancet."},{"issue":"6","key":"7432_CR3","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","volume":"43","author":"ES Connolly","year":"2012","unstructured":"Connolly ES, Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the american heart association\/american stroke association. Stroke. 2012;43(6):1711\u201337.","journal-title":"Stroke."},{"issue":"5","key":"7432_CR4","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1212\/CON.0000000000000217","volume":"21","author":"JI Suarez","year":"2015","unstructured":"Suarez JI. Diagnosis and management of subarachnoid hemorrhage. Contin Lifelong Learn Neurol. 2015;21(5):1263\u201387.","journal-title":"Contin Lifelong Learn Neurol."},{"issue":"2","key":"7432_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","volume":"15","author":"MN Diringer","year":"2011","unstructured":"Diringer MN, Bleck TP, Hemphill JC, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: Recommendations from the neurocritical care society\u2019s multidisciplinary consensus conference. Neurocrit Care. 2011;15(2):211\u201340.","journal-title":"Neurocrit Care."},{"issue":"2","key":"7432_CR6","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1097\/CCM.0000000000002059","volume":"45","author":"AA Udy","year":"2017","unstructured":"Udy AA, Vladic C, Saxby ER, Cohen J, Delaney A, Flower O, et al. Subarachnoid hemorrhage patients admitted to intensive care in Australia and New Zealand: a multicenter cohort analysis of in-hospital mortality over 15 years. Crit Care Med. 2017;45(2):e135-45.","journal-title":"Crit Care Med."},{"key":"7432_CR7","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1097\/ALN.0000000000003558","volume":"6","author":"D Sharma","year":"2020","unstructured":"Sharma D. Perioperative management of aneurysmal subarachnoid hemorrhage: a narrative review. Anesthesiology. 2020;6:1283\u2013305.","journal-title":"Anesthesiology."},{"issue":"9","key":"7432_CR8","doi-asserted-by":"publisher","first-page":"e73760","DOI":"10.1371\/journal.pone.0073760","volume":"8","author":"M Korja","year":"2013","unstructured":"Korja M, Silventoinen K, Laatikainen T, Jousilahti P, Salomaa V, Hernesniemi J, et al. Risk factors and their combined effects on the incidence rate of subarachnoid hemorrhage - a population-based cohort study. PLoS One. 2013;8(9):e73760.","journal-title":"PLoS One"},{"key":"7432_CR9","doi-asserted-by":"publisher","unstructured":"Fujii, M., Yan, J., Rolland, W. B., Soejima, Y., Caner, B., & Zhang, J. H. (2013). Early brain injury, an evolving frontier in subarachnoid hemorrhage research. In Translational Stroke Research (Vol. 4, Issue 4, pp. 432\u2013446). Springer US. https:\/\/doi.org\/10.1007\/s12975-013-0257-2.","DOI":"10.1007\/s12975-013-0257-2"},{"issue":"2","key":"7432_CR10","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s12028-017-0471-y","volume":"28","author":"J Savarraj","year":"2018","unstructured":"Savarraj J, Parsha K, Hergenroeder G, Ahn S, Chang TR, Kim DH, et al. Early brain injury associated with systemic inflammation after subarachnoid hemorrhage. Neurocrit Care. 2018;28(2):203\u201311.","journal-title":"Neurocrit Care."},{"issue":"11","key":"7432_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/sj.jcbfm.9600283","volume":"26","author":"WJ Cahill","year":"2006","unstructured":"Cahill WJ, Calvert JH, Zhang JH. Mechanisms of early brain injury after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2006;26(11):1341\u201353.","journal-title":"J Cereb Blood Flow Metab."},{"issue":"12","key":"7432_CR12","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1007\/s11883-017-0690-x","volume":"19","author":"JR Geraghty","year":"2017","unstructured":"Geraghty JR, Testai FD. Delayed cerebral ischemia after subarachnoid hemorrhage: beyond vasospasm and towards a multifactorial pathophysiology. Curr Atheroscler Rep. 2017;19(12):50.","journal-title":"Curr Atheroscler Rep"},{"key":"7432_CR13","doi-asserted-by":"publisher","unstructured":"Dorhout Mees, S. M., Rinkel, G. J. E., Feigin, V. L., Algra, A., van den Bergh, W. M., Vermeulen, M., & van Gijn, J. (2007). Calcium antagonists for aneurysmal subarachnoid haemorrhage. In Cochrane Database of Systematic Reviews (Issue 3). https:\/\/doi.org\/10.1002\/14651858.CD000277.pub3.","DOI":"10.1002\/14651858.CD000277.pub3"},{"key":"7432_CR14","doi-asserted-by":"publisher","unstructured":"Dorhout Mees, S. M., van den Bergh, W. M., Algra, A., & Rinkel, G. J. E. (2007). Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. In Cochrane Database of Systematic Reviews (Issue 2). https:\/\/doi.org\/10.1002\/14651858.CD006184.pub2.","DOI":"10.1002\/14651858.CD006184.pub2"},{"issue":"3","key":"7432_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/bja\/aes264","volume":"109","author":"MJ Rowland","year":"2012","unstructured":"Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KTS. Delayed cerebral ischaemia after subarachnoid haemorrhage: Looking beyond vasospasm. Br J Anaesth. 2012;109(3):315\u201329.","journal-title":"Br J Anaesth"},{"issue":"3","key":"7432_CR16","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/WNP.0000000000000273","volume":"33","author":"B Foreman","year":"2016","unstructured":"Foreman B. The pathophysiology of delayed cerebral ischemia. J Clin Neurophysiol. 2016;33(3):174\u201382.","journal-title":"J Clin Neurophysiol"},{"issue":"10","key":"7432_CR17","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, et al. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20135.","journal-title":"Stroke"},{"issue":"2","key":"7432_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/bja\/80.2.255","volume":"80","author":"T Goto","year":"1998","unstructured":"Goto T, Suwa K, Uezono S, Ichinose F, Uchiyama M, Morita S. The blood-gas partition coefficient of xenon may be lower than generally accepted. Br J Anaesth. 1998;80(2):255\u20136.","journal-title":"Br J Anaesth"},{"issue":"5","key":"7432_CR19","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/bja\/aeg232","volume":"91","author":"RD Sanders","year":"2003","unstructured":"Sanders RD, Franks NP, Maze M. Xenon: No stranger to anaesthesia. Br J Anaesth. 2003;91(5):709\u201317.","journal-title":"Br J Anaesth"},{"key":"7432_CR20","doi-asserted-by":"publisher","first-page":"511","DOI":"10.3389\/fneur.2017.00511","volume":"8","author":"M Veldeman","year":"2017","unstructured":"Veldeman M, Coburn M, Rossaint R, Clusmann H, Nolte K, Kremer B, et al. Xenon reduces neuronal hippocampal damage and alters the pattern of microglial activation after experimental subarachnoid hemorrhage: a randomized controlled animal trial. Front Neurol. 2017;8:511.","journal-title":"Front Neurol"},{"key":"7432_CR21","doi-asserted-by":"publisher","unstructured":"Franks N, Dickinson R, de Sousa S, et al. How does xenon produce anaesthesia?. Nature. 1998;396:324. https:\/\/doi.org\/10.1038\/24525.","DOI":"10.1038\/24525"},{"issue":"6","key":"7432_CR22","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1097\/00000542-200206000-00031","volume":"96","author":"S Wilhelm","year":"2002","unstructured":"Wilhelm S, Ma D, Maze M, Franks NP. Effects of xenon on in vitro and in vivo models of neuronal injury. Anesthesiology. 2002;96(6):1485\u201391.","journal-title":"Anesthesiology"},{"issue":"5","key":"7432_CR23","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1093\/bja\/89.5.739","volume":"89","author":"D Ma","year":"2002","unstructured":"Ma D, Wilhelm S, Maze M, Franks NP. Neuroprotective and neurotoxic properties of the \u201cinert\u201d gas, xenon. Br J Anaesth. 2002;89(5):739\u201346.","journal-title":"Br J Anaesth"},{"issue":"3","key":"7432_CR24","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/00000542-200303000-00017","volume":"98","author":"D Ma","year":"2003","unstructured":"Ma D, Yang H, Lynch J, Franks NP, Maze M, Grocott HP. Xenon attenuates cardiopulmonary bypass-induced neurologic and neurocognitive dysfunction in the rat. Anesthesiology. 2003;98(3):690\u20138.","journal-title":"Anesthesiology."},{"issue":"3","key":"7432_CR25","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/00000542-200309000-00034","volume":"99","author":"D Ma","year":"2003","unstructured":"Ma D, Hossain M, Rajakumaraswamy N, Franks NP, Maze M. Combination of xenon and isoflurane produces a synergistic protective effect against oxygen-glucose deprivation injury in a neuronal-glial co-culture model. Anesthesiology. 2003;99(3):748\u201351.","journal-title":"Anesthesiology"},{"issue":"4","key":"7432_CR26","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1097\/00000542-200310000-00020","volume":"99","author":"HM Homi","year":"2003","unstructured":"Homi HM, Yokoo N, Ma D, Warner DS, Franks NP, Maze M, et al. The neuroprotective effect of xenon administration during transient middle cerebral artery occlusion in mice. Anesthesiology. 2003;99(4):876\u201381.","journal-title":"Anesthesiology."},{"issue":"5","key":"7432_CR27","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/00000542-200505000-00011","volume":"102","author":"M Schmidt","year":"2005","unstructured":"Schmidt M, Marx T, Gl\u00f6ggl E, Reinelt H, Schirmer U. Xenon attenuates cerebral damage after ischemia in pigs. Anesthesiology. 2005;102(5):929\u201336.","journal-title":"Anesthesiology."},{"issue":"8","key":"7432_CR28","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1097\/CCM.0b013e3181802874","volume":"36","author":"M Fries","year":"2008","unstructured":"Fries M, Nolte KW, Coburn M, Rex S, Timper A, Kottmann K, et al. Xenon reduces neurohistopathological damage and improves the early neurological deficit after cardiac arrest in pigs. Crit Care Med. 2008;36(8):2420\u20136.","journal-title":"Crit Care Med."},{"issue":"2","key":"7432_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1161\/01.STR.0000198867.31134.ac","volume":"37","author":"J Dingley","year":"2006","unstructured":"Dingley J, Tooley J, Porter H, Thoresen M. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia. Stroke. 2006;37(2):501\u20136.","journal-title":"Stroke."},{"issue":"2","key":"7432_CR30","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1002\/ana.20547","volume":"58","author":"D Ma","year":"2005","unstructured":"Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, et al. Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol. 2005;58(2):182\u201393.","journal-title":"Ann Neurol."},{"issue":"2","key":"7432_CR31","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/01.CCM.0B013E3181611F8A6","volume":"36","author":"M Coburn","year":"2008","unstructured":"Coburn M, Maze M, Franks NP. The neuroprotective effects of xenon and helium in an in vitro model of traumatic brain injury. Crit Care Med. 2008;36(2):588\u201395.","journal-title":"Crit Care Med."},{"issue":"1","key":"7432_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/CCM.0000000000000624","volume":"43","author":"R Campos-Pires","year":"2015","unstructured":"Campos-Pires R, Armstrong SP, Sebastiani A, Luh C, Gruss M, Radyushkin K, et al. Xenon improves neurologic outcome and reduces secondary injury following trauma in an in vivo model of traumatic brain injury. Crit Care Med. 2015;43(1):149\u201358.","journal-title":"Crit Care Med."},{"issue":"1","key":"7432_CR33","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bja.2019.02.032","volume":"123","author":"R Campos-Pires","year":"2019","unstructured":"Campos-Pires R, Hirnet T, Valeo F, Ong BE, Radyushkin K, Aldhoun J, et al. Xenon improves long-term cognitive function, reduces neuronal loss and chronic neuroinflammation, and improves survival after traumatic brain injury in mice. Br J Anaesth. 2019;123(1):60\u201373.","journal-title":"Br J Anaesth"},{"issue":"4","key":"7432_CR34","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1097\/CCM.0b013e31823c8ce7","volume":"40","author":"M Fries","year":"2012","unstructured":"Fries M, Br\u00fccken A, \u00c7izen A, Westerkamp M, L\u00f6wer C, Deike-Glindemann J, et al. Combining xenon and mild therapeutic hypothermia preserves neurological function after prolonged cardiac arrest in pigs. Crit Care Med. 2012;40(4):1297\u2013303.","journal-title":"Crit Care Med."},{"issue":"3","key":"7432_CR35","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/ana.22016","volume":"68","author":"E Chakkarapani","year":"2010","unstructured":"Chakkarapani E, Dingley J, Liu X, Hoque N, Aquilina K, Porter H, et al. Xenon enhances hypothermic neuroprotection in asphyxiated newborn pigs. Ann Neurol. 2010;68(3):330\u201341.","journal-title":"Ann Neurol."},{"issue":"6","key":"7432_CR36","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1097\/ALN.0b013e3182746b81","volume":"117","author":"SP Sheng","year":"2012","unstructured":"Sheng SP, Lei B, James ML, Lascola CD, Venkatraman TN, Jung JY, et al. Xenon neuroprotection in experimental stroke: interactions with hypothermia and intracerebral hemorrhage. Anesthesiology. 2012;117(6):1262\u201375.","journal-title":"Anesthesiology"},{"issue":"4","key":"7432_CR37","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1161\/STROKEAHA.107.499822","volume":"39","author":"C Hobbs","year":"2008","unstructured":"Hobbs C, Thoresen M, Tucker A, Aquilina K, Chakkarapani E, Dingley J. Xenon and hypothermia combine additively, offering long-term functional and histopathologic neuroprotection after neonatal hypoxia\/ischemia. Stroke. 2008;39(4):1307\u201313.","journal-title":"Stroke"},{"issue":"2","key":"7432_CR38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/bja\/aei023","volume":"94","author":"M Coburn","year":"2005","unstructured":"Coburn M, Kunitz O, Baumert JH, Hecker K, Haaf S, Z\u00fchlsdorff A, et al. Randomized controlled trial of the haemodynamic and recovery effects of xenon or propofol anaesthesia. Br J Anaesth. 2005;94(2):198\u2013202.","journal-title":"Br J Anaesth"},{"issue":"1","key":"7432_CR39","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1097\/00000542-200301000-00005","volume":"98","author":"R Rossaint","year":"2003","unstructured":"Rossaint R, Reyle-Hahn M, Schulte Am Esch J, Scholz J, Scherpereel P, Vallet B, et al. Multicenter randomized comparison of the efficacy and safety of xenon and isoflurane in patients undergoing elective surgery. Anesthesiology. 2003;98(1):6\u201313.","journal-title":"Anesthesiology"},{"issue":"21","key":"7432_CR40","doi-asserted-by":"publisher","first-page":"2652","DOI":"10.1016\/j.jacc.2017.09.1088","volume":"70","author":"O Arola","year":"2017","unstructured":"Arola O, Saraste A, Laitio R, Airaksinen J, Hynninen M, B\u00e4cklund M, et al. Inhaled Xenon attenuates myocardial damage in comatose survivors of out-of-hospital cardiac arrest: the Xe-Hypotheca trial. J Am Coll Cardiol. 2017;70(21):2652\u201360.","journal-title":"J Am Coll Cardiol."},{"issue":"1","key":"7432_CR41","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/sj.bjp.0706063","volume":"144","author":"NC Weber","year":"2005","unstructured":"Weber NC, Toma O, Wolter JI, Obal D, M\u00fcllenheim J, Preckel B, et al. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-\u03b5 and p38 MAPK. Br J Pharmacol. 2005;144(1):123\u201332.","journal-title":"Br J Pharmacol"},{"issue":"6","key":"7432_CR42","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1097\/ALN.0000000000001873","volume":"127","author":"J Hofland","year":"2017","unstructured":"Hofland J, Ouattara A, Fellahi JL, Gruenewald M, Hazebroucq J, Ecoffey C, et al. Effect of xenon anesthesia compared to sevoflurane and total intravenous anesthesia for coronary artery bypass graft surgery on postoperative cardiac troponin release an international, multicenter, phase 3, single-blinded, randomized noninferiority trial. Anesthesiology. 2017;127(6):918\u201333.","journal-title":"Anesthesiology"},{"issue":"11","key":"7432_CR43","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1001\/jama.2016.1933","volume":"315","author":"R Laitio","year":"2016","unstructured":"Laitio R, Hynninen M, Arola O, Virtanen S, Parkkola R, Saunavaara J, et al. Effect of inhaled xenon on cerebral white matter damage in comatose survivors of out-of-hospital cardiac arrest: a randomized clinical trial. JAMA - J Am Med Assoc. 2016;315(11):1120\u20138.","journal-title":"JAMA - J Am Med Assoc."},{"issue":"8","key":"7432_CR44","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1161\/STROKEAHA.117.016811","volume":"48","author":"I Fragata","year":"2017","unstructured":"Fragata I, Alves M, Papoila AL, Nunes AP, Ferreira P, Canto-Moreira N, et al. Early prediction of delayed ischemia and functional outcome in acute subarachnoid hemorrhage: role of diffusion tensor imaging. Stroke. 2017;48(8):2091\u20137.","journal-title":"Stroke"},{"key":"7432_CR45","first-page":"346","volume":"2013","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, G\u00f8tzsche PC, Altman DG, Mann H, Berlin JA, SPIRIT, et al. explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;2013:346.","journal-title":"BMJ."},{"key":"7432_CR46","doi-asserted-by":"publisher","unstructured":"Hoh BL, Ko NU, Amin-Hanjani S, Hsiang-Yi Chou S, Cruz-Flores S, Dangayach NS, Derdeyn CP, Du R, H\u00e4nggi D, Hetts SW, Ifejika NL, Johnson R, Keigher KM, Leslie-Mazwi TM, Lucke-Wold B, Rabinstein AA, Robicsek SA, Stapleton CJ, Suarez JI, Tjoumakaris SI, \u2026 Welch BG. 2023 Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association\/American Stroke Association. Stroke. 2023;10.1161\/STR.0000000000000436. Advance online publication. https:\/\/doi.org\/10.1161\/STR.0000000000000436.","DOI":"10.1161\/STR.0000000000000436"},{"key":"7432_CR47","doi-asserted-by":"publisher","unstructured":"Grinnon ST, Miller K, Marler JR, Lu Y, Stout A, Odenkirchen J, Kunitz S. National Institute of Neurological Disorders and Stroke Common Data Element Project - approach and methods. Clin Trials (London, England). 2012;9(3):322\u201329. https:\/\/doi.org\/10.1177\/1740774512438980.","DOI":"10.1177\/1740774512438980"},{"issue":"Suppl 1","key":"7432_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s12028-019-00726-3","volume":"30","author":"AL de Oliveira Manoel","year":"2019","unstructured":"de Oliveira Manoel AL, van der Jagt M, Amin-Hanjani S, Bambakidis NC, Brophy GM, Bulsara K, et al. Common data elements for unruptured intracranial aneurysms and aneurysmal subarachnoid hemorrhage: recommendations from the working group on hospital course and acute therapies\u2014proposal of a multidisciplinary research group. Neurocrit Care. 2019;30(Suppl 1):36\u201345.","journal-title":"Neurocrit Care"},{"issue":"11","key":"7432_CR49","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/hbm.22099","volume":"34","author":"B Jeurissen","year":"2013","unstructured":"Jeurissen B, Leemans A, Tournier JD, Jones DK, Sijbers J. Investigating the prevalence of complex fiber configurations in white matter tissue with diffusion magnetic resonance imaging. Hum Brain Mapp. 2013;34(11):2747\u201366.","journal-title":"Hum Brain Mapp"},{"issue":"3","key":"7432_CR50","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1016\/j.neuroimage.2004.07.037","volume":"23","author":"JD Tournier","year":"2004","unstructured":"Tournier JD, Calamante F, Gadian DG, Connelly A. Direct estimation of the fiber orientation density function from diffusion-weighted MRI data using spherical deconvolution. Neuroimage. 2004;23(3):1176\u201385.","journal-title":"Neuroimage"},{"issue":"4","key":"7432_CR51","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/j.neuroimage.2007.02.016","volume":"35","author":"JD Tournier","year":"2007","unstructured":"Tournier JD, Calamante F, Connelly A. Robust determination of the fibre orientation distribution in diffusion MRI: Non-negativity constrained super-resolved spherical deconvolution. Neuroimage. 2007;35(4):1459\u201372.","journal-title":"Neuroimage"},{"issue":"3","key":"7432_CR52","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/hbm.21032","volume":"32","author":"B Jeurissen","year":"2011","unstructured":"Jeurissen B, Leemans A, Jones DK, Tournier JD, Sijbers J. Probabilistic fiber tracking using the residual bootstrap with constrained spherical deconvolution. Hum Brain Mapp. 2011;32(3):461\u201379.","journal-title":"Hum Brain Mapp"},{"key":"7432_CR53","doi-asserted-by":"publisher","unstructured":"Bullmore E, Sporns O. Complex brain networks: graph theoretical analysis of structural and functional systems. Nat Rev Neurosci. 2009;10:186\u201398. https:\/\/doi.org\/10.1038\/nrn2575.","DOI":"10.1038\/nrn2575"},{"issue":"6","key":"7432_CR54","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1002\/ana.21796","volume":"66","author":"BA Radlinska","year":"2009","unstructured":"Radlinska BA, Ghinani SA, Lyon P, Jolly D, Soucy JP, Minuk J, et al. Multimodal microglia imaging of fiber tracts in acute subcortical stroke. Ann Neurol. 2009;66(6):825\u201332.","journal-title":"Ann Neurol"},{"issue":"3","key":"7432_CR55","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.1212\/NXI.0000000000000443","volume":"5","author":"E Rissanen","year":"2018","unstructured":"Rissanen E, Tuisku J, Vahlberg T, Sucksdorff M, Paavilainen T, Parkkola R, et al. Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm. 2018;5(3):e443.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"7432_CR56","doi-asserted-by":"publisher","first-page":"939","DOI":"10.2967\/jnumed.113.131698","volume":"55","author":"E Rissanen","year":"2014","unstructured":"Rissanen E, Tuisku J, Rokka J, Paavilainen T, Parkkola R, Rinne JO, et al. In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand11C-PK11195. J Nucl Med. 2014;55(6):939\u201344.","journal-title":"J Nucl Med"},{"issue":"5094","key":"7432_CR57","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1126\/science.8424175","volume":"259","author":"S Mathias","year":"1993","unstructured":"Mathias S, Younes A, Kan CC, Orlow I, Joseph C, Kolesnick RN. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1\u03b2. Science (80- ). 1993;259(5094):519\u201322.","journal-title":"Science (80- )"},{"issue":"1","key":"7432_CR58","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41537-020-00110-7","volume":"6","author":"AM Dickens","year":"2020","unstructured":"Dickens AM, Borgan F, Laurikainen H, Lamichhane S, Marques T, R\u00f6nkk\u00f6 T, et al. Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosis. NPJ Schizophr. 2020;6(1):21.","journal-title":"NPJ Schizophr"},{"issue":"8","key":"7432_CR59","doi-asserted-by":"publisher","first-page":"3058","DOI":"10.1021\/ac103308x","volume":"83","author":"S Castillo","year":"2011","unstructured":"Castillo S, Mattila I, Miettinen J, Ore\u0161i\u010d M, Hy\u00f6tyl\u00e4inen T. Data analysis tool for comprehensive two-dimensional gas chromatography\/time-of-flight mass spectrometry. Anal Chem. 2011;83(8):3058\u201367.","journal-title":"Anal Chem"},{"key":"7432_CR60","doi-asserted-by":"publisher","unstructured":"Nygren H, Sepp\u00e4nen-Laakso T, Castillo S, Hy\u00f6tyl\u00e4inen T, Ore\u0161i\u010d M. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol (Clifton, N.J.). 2011;708:247\u201357. https:\/\/doi.org\/10.1007\/978-1-61737-985-7_15.","DOI":"10.1007\/978-1-61737-985-7_15"},{"key":"7432_CR61","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/1471-2105-11-395","volume":"11","author":"T Pluskal","year":"2010","unstructured":"Pluskal T, Castillo S, Villar-Briones A, Ore\u0161i\u010d M. MZmine 2: Modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinformatics. 2010;11:395.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"7432_CR62","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"key":"7432_CR63","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"4","key":"7432_CR64","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1681\/ASN.2008070712","volume":"20","author":"M Daqing","year":"2009","unstructured":"Daqing M, Lim T, Xu J, Tang H, Wan Y, Zhao H, Hossain M, Maxwell PH, Maze M. Xenon preconditioning protects against renal ischemic-reperfusion injury via hif-1\u03b1 activation. J Am Soc Nephrol. 2009;20(4):713\u201320.","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"7432_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10072-011-0828-5","volume":"33","author":"BB Kostandy","year":"2012","unstructured":"Kostandy BB. The role of glutamate in neuronal ischemic injury: the role of spark in fire. Neurol Sci. 2012;33(2):223\u201337.","journal-title":"Neurol Sci"},{"issue":"3","key":"7432_CR66","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/ALN.0b013e3181cea398","volume":"112","author":"P Banks","year":"2010","unstructured":"Banks P, Franks NP, Dickinson R. Competitive inhibition at the glycine site of the n-methyl-d-aspartate receptor mediates xenon neuroprotection against hypoxia-ischemia. Anesthesiology. 2010;112(3):614\u201322.","journal-title":"Anesthesiology"},{"issue":"4","key":"7432_CR67","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/bja\/aei080","volume":"94","author":"A Dinse","year":"2005","unstructured":"Dinse A, F\u00f6hr KJ, Georgieff M, Beyer C, Bulling A, Weigt HU. Xenon reduces glutamate-, AMPA-, and kainate-induced membrane currents in cortical neurones. Br J Anaesth. 2005;94(4):479\u201385.","journal-title":"Br J Anaesth"},{"issue":"2","key":"7432_CR68","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1124\/mol.65.2.443","volume":"65","author":"M Gruss","year":"2004","unstructured":"Gruss M, Bushell TJ, Bright DP, Lieb WR, Mathie A, Franks NP. Two-Pore-Domain K+ channels are a novel target for the anesthetic gases xenon, nitrous oxide, and cyclopropane. Mol Pharmacol. 2004;65(2):443\u201352.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"7432_CR69","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1097\/ALN.0b013e31819dadc7","volume":"110","author":"C Bantel","year":"2009","unstructured":"Bantel C, Maze M, Trapp S. Neuronal preconditioning by inhalational anesthetics: Evidence for the role of plasmalemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2009;110(5):986\u201395.","journal-title":"Anesthesiology"},{"issue":"6","key":"7432_CR70","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1097\/01.anes.0000267596.57497.92","volume":"106","author":"RM Laitio","year":"2007","unstructured":"Laitio RM, Kaisti KK, L\u00e5angsj\u00f6 JW, Aalto S, Salmi E, Maksimow A, et al. Effects of xenon anesthesia on cerebral blood flow in humans: A positron emission tomography study. Anesthesiology. 2007;106(6):1128\u201333.","journal-title":"Anesthesiology"},{"issue":"2","key":"7432_CR71","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1213\/ane.0b013e31818ffc9d","volume":"108","author":"RM Laitio","year":"2009","unstructured":"Laitio RM, L\u00e5ngsj\u00f6 JW, Aalto S, Kaisti KK, Salmi E, Maksimow A, et al. The effects of xenon anesthesia on the relationship between cerebral glucose metabolism and blood flow in healthy subjects: a positron emission tomography study. Anesth Analg. 2009;108(2):593\u2013600.","journal-title":"Anesth Analg"},{"key":"7432_CR72","doi-asserted-by":"publisher","unstructured":"Fragata I, Alves M, Papoila AL, Ferreira P, Nunes AP, Moreira NC, Canh\u00e3o P. Prediction of clinical outcome in subacute subarachnoid hemorrhage using diffusion tensor imaging. J Neurosurg. 2018:1\u20139. Advance online publication. https:\/\/doi.org\/10.3171\/2017.10.JNS171793.","DOI":"10.3171\/2017.10.JNS171793"},{"issue":"6","key":"7432_CR73","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1227\/NEU.0000000000001325","volume":"79","author":"S Sener","year":"2016","unstructured":"Sener S, Van Hecke W, Feyen BFE, Van Der Steen G, Pullens P, Van De Hauwe L, et al. Diffusion tensor imaging: a possible biomarker in severe traumatic brain injury and aneurysmal subarachnoid hemorrhage? Neurosurgery. 2016;79(6):786\u201393.","journal-title":"Neurosurgery"},{"issue":"8","key":"7432_CR74","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1161\/STROKEAHA.112.661116","volume":"43","author":"SS Yeo","year":"2012","unstructured":"Yeo SS, Choi BY, Chang CH, Kim SH, Jung YJ, Jang SH. Evidence of corticospinal tract injury at midbrain in patients with subarachnoid hemorrhage. Stroke. 2012;43(8):2239\u201341.","journal-title":"Stroke"},{"issue":"7","key":"7432_CR75","doi-asserted-by":"publisher","first-page":"e005613","DOI":"10.1136\/bmjopen-2014-005613","volume":"4","author":"SH Jang","year":"2014","unstructured":"Jang SH, Choi BY, Kim SH, Chang CH, Jung YJ, Kwon HG. Injury of the mammillothalamic tract in patients with subarachnoid haemorrhage: a retrospective diffusion tensor imaging study. BMJ Open. 2014;4(7):e005613.","journal-title":"BMJ Open"},{"issue":"9","key":"7432_CR76","doi-asserted-by":"publisher","first-page":"2608","DOI":"10.1093\/brain\/awv180","volume":"138","author":"TT Kummer","year":"2015","unstructured":"Kummer TT, Magnoni S, MacDonald CL, Dikranian K, Milner E, Sorrell J, et al. Experimental subarachnoid haemorrhage results in multifocal axonal injury. Brain. 2015;138(9):2608\u201318.","journal-title":"Brain"},{"issue":"6","key":"7432_CR77","doi-asserted-by":"publisher","first-page":"e36","DOI":"10.1093\/brain\/awx084","volume":"140","author":"Y Wu","year":"2017","unstructured":"Wu Y, Peng J, Pang J, Sun X, Jiang Y. Potential mechanisms of white matter injury in the acute phase of experimental subarachnoid haemorrhage. Brain. 2017;140(6):e36.","journal-title":"Brain"},{"issue":"3","key":"7432_CR78","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1006\/nimg.2002.1267","volume":"17","author":"SK Song","year":"2002","unstructured":"Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage. 2002;17(3):1429\u201336.","journal-title":"Neuroimage"},{"issue":"3","key":"7432_CR79","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1016\/j.neuroimage.2003.07.005","volume":"20","author":"SK Song","year":"2003","unstructured":"Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003;20(3):1714\u201322.","journal-title":"Neuroimage"},{"issue":"1","key":"7432_CR80","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.neuroimage.2005.01.028","volume":"26","author":"SK Song","year":"2005","unstructured":"Song SK, Yoshino J, Le TQ, Lin SJ, Sun SW, Cross AH, et al. Demyelination increases radial diffusivity in corpus callosum of mouse brain. Neuroimage. 2005;26(1):132\u201340.","journal-title":"Neuroimage"},{"issue":"11","key":"7432_CR81","doi-asserted-by":"publisher","first-page":"3478","DOI":"10.1161\/STROKEAHA.109.556753","volume":"40","author":"M Hravnak","year":"2009","unstructured":"Hravnak M, Frangiskakis JM, Crago EA, Chang Y, Tanabe M, Gorcsan J, et al. Elevated cardiac troponin i and relationship to persistence of electrocardiographic and echocardiographic abnormalities after aneurysmal subarachnoid hemorrhage. Stroke. 2009;40(11):3478\u201384.","journal-title":"Stroke"},{"issue":"4","key":"7432_CR82","doi-asserted-by":"publisher","first-page":"741","DOI":"10.3171\/jns.2003.98.4.0741","volume":"98","author":"E Deibert","year":"2003","unstructured":"Deibert E, Barzilai B, Braverman AC, Edwards DF, Aiyagari V, Dacey R, et al. Clinical significance of elevated troponin I levels in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg. 2003;98(4):741\u20136.","journal-title":"J Neurosurg"},{"issue":"3","key":"7432_CR83","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/01.CCM.0000201903.46435.35","volume":"34","author":"KE Wartenberg","year":"2006","unstructured":"Wartenberg KE, Schmidt JM, Claassen J, Temes RE, Frontera JA, Ostapkovich N, et al. Impact of medical complications on outcome after subarachnoid hemorrhage. Crit Care Med. 2006;34(3):617\u201323.","journal-title":"Crit Care Med"},{"issue":"1","key":"7432_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3171\/jns.2006.105.1.15","volume":"105","author":"N Banki","year":"2006","unstructured":"Banki N, Kopelnik A, Tung P, Lawton MT, Gress D, Drew B, et al. Prospective analysis of prevalence, distribution, and rate of recovery of left ventricular systolic dysfunction in patients with subarachnoid hemorrhage. J Neurosurg. 2006;105(1):15\u201320.","journal-title":"J Neurosurg"},{"issue":"12","key":"7432_CR85","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1007\/s00134-006-0408-y","volume":"32","author":"S Naredi","year":"2006","unstructured":"Naredi S, Lambert G, Friberg P, Z\u00e4ll S, Ed\u00e9n E, Rydenhag B, et al. Sympathetic activation and inflammatory response in patients with subarachnoid haemorrhage. Intensive Care Med. 2006;32(12):1955\u201361.","journal-title":"Intensive Care Med"},{"issue":"4","key":"7432_CR86","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1161\/01.STR.31.4.901","volume":"31","author":"S Naredi","year":"2000","unstructured":"Naredi S, Lambert G, Ed\u00e9n E, Z\u00e4ll S, Runnerstam M, Rydenhag B, et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke. 2000;31(4):901\u20136.","journal-title":"Stroke"},{"issue":"3","key":"7432_CR87","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1385\/NCC:5:3:243","volume":"5","author":"VH Lee","year":"2006","unstructured":"Lee VH, Oh JK, Mulvagh SL, Wijdicks EFM. Mechanisms in neurogenic stress cardiomyopathy after aneurysmal subarachnoid hemorrhage. Neurocrit Care. 2006;5(3):243\u20139.","journal-title":"Neurocrit Care"},{"issue":"2","key":"7432_CR88","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000334660","volume":"33","author":"M Moussouttas","year":"2012","unstructured":"Moussouttas M, Huynh TT, Khoury J, Lai EW, Dombrowski K, Pello S, et al. Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage. Cerebrovasc Dis. 2012;33(2):173\u201381.","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"7432_CR89","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1161\/01.STR.0000114874.96688.54","volume":"35","author":"P Tung","year":"2004","unstructured":"Tung P, Kopelnik A, Banki N, Ong K, Ko N, Lawton MT, et al. Predictors of neurocardiogenic injury after subarachnoid hemorrhage. Stroke. 2004;35(2):548\u201351.","journal-title":"Stroke"},{"issue":"5","key":"7432_CR90","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1179\/1743132812Y.0000000033","volume":"34","author":"T Ogura","year":"2012","unstructured":"Ogura T, Satoh A, Ooigawa H, Sugiyama T, Takeda R, Fushihara G, et al. Characteristics and prognostic value of acute catecholamine surge in patients with aneurysmal subarachnoid hemorrhage. Neurol Res. 2012;34(5):484\u201390.","journal-title":"Neurol Res"},{"issue":"3","key":"7432_CR91","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s12028-010-9447-x","volume":"13","author":"RE Temes","year":"2010","unstructured":"Temes RE, Tessitore E, Schmidt JM, Naidech AM, Fernandez A, Ostapkovich ND, et al. Left ventricular dysfunction and cerebral infarction from vasospasm after subarachnoid hemorrhage. Neurocrit Care. 2010;13(3):359\u201365.","journal-title":"Neurocrit Care"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-023-07432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-023-07432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T17:01:48Z","timestamp":1687194108000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-023-07432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,19]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["7432"],"URL":"https:\/\/doi.org\/10.1186\/s13063-023-07432-8","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,19]]},"assertion":[{"value":"27 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This trial has been approved by the National Committee on Medical Research Ethics TUKIJA (June 15, 2020; Dnro 67\/06.00.01\/2020) and by the Finnish Medicines Agency FIMEA (September 18, 2020; KLno. 60\/ 2020) and registered in the European Union database C-TIS portal (June 22, 2022, no. 2022-500596-32-00). In addition, the Hospital District of Southwest Finland has approved this trial (October 25, 2021; 194\/2021). The principal investigator (PI) is responsible for keeping TUKIJA and FIMEA informed of any SAEs and amendments as requested. All amendments will be submitted to TUKIJA and FIMEA via EU C-TIS portal. The PI should file all correspondence with the TUKIJA and FIMEA in the Investigator\u2019s Study File.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Model consent forms for both patient and next of kin, as well as all documentation given to the study subject and family member, have been attached as separate documents with this submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"AS received research grants from the Academy of Finland, Juselius Foundation, and the Finnish Foundation for Cardiovascular Research; consultancy fees from Astra Zeneca, Boehringer Ingelheim, and Pfizer; and speaker fees from Abbott, Astra Zeneca, Bayer, and Novartis unrelated to the current study.All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"417"}}